South London and Maudsley NHS Foundation Trust is using the Oxehealth Digital Care Assistant in the seclusion suite of Eileen Skellern 1 ward.
The women's ward has a tradition of improving the therapeutic environment and is using the Digital Care Assistant to support clinical staff to monitor the safety and physical health of patients when they are unwell.
Fitbit (NYSE:FIT) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), as well as Conformité Européenne (CE) marking in the European Union, for its electrocardiogram (ECG) app to assess heart rhythm for atrial fibrillation (AFib), a condition that affects more than 33.5 million people globally. 
Cerner Corporation is pleased to announce a new relationship with Hampshire and Isle of Wight (HIOW) health and care system to enable their population health management journey to transform the planning and delivery of health and care services across the region.
The initiative will see the implementation of Cerner’s population health management data platform, HealtheIntent ®, alongside HealtheEDW SM, a big data analytics solution.
A new type of technology for the NHS is expected to help re-energise the healthcare IT market, following the formal UK launch of Miya Precision by smart health tech company Alcidion.
Miya Precision integrates information from the healthcare organisation's current systems, uses it to automate routine tasks, care plans and pathways, and overlays existing data with advanced clinical decision support to make otherwise static information clinically valuable.
Remote Patient Monitoring solution included on Crown Commercial Services Spark: Technology Innovation Marketplace.
Healthcare organisations now have a simple route to procure personalised monitoring for people living with chronic conditions to address post-Covid care challenges and the population health management agenda.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today presented new approaches to health and healthcare, and the shift to health-at-home, at its virtual consumer health press event. Against the backdrop of COVID-19, the need for consumers to stay as healthy as possible is more relevant than ever. 
Norfolk and Waveney Clinical Commissioning Group to support prescribers to improve the quality and safety of prescribing through deploying prescribing decision technology FDB OptimiseRx.
A newly merged clinical commissioning group responsible for planning and buying local health services for more than a million patients, has signed a new agreement to support primary care prescribers to improve quality and patient safety.